{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:41:23Z","timestamp":1790764883788,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.tmrv.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:40:50Z","timestamp":1593218450000},"page":"172-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyperhemolytic Transfusion Reaction in Non-Hemoglobinopathy Patients and Terminal Complement Pathway Activation: Case Series and Review of the Literature"],"prefix":"10.1016","volume":"34","author":[{"given":"Joan","family":"Cid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"Bail\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Diaz-Ricart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2020.06.002_bb0005","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/S0140-6736(15)01313-6","article-title":"Transfusion reactions: prevention, diagnosis, and treatment","volume":"388","author":"Delaney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0010","series-title":"Immune hemolytic anemias","first-page":"319","article-title":"Unusual aspectes of acquired immune hemolytic anemias","author":"Petz","year":"2004"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-3148.2012.01151.x","article-title":"What do we mean by \"Hyperhaemolysis\" and what is the cause?","volume":"22","author":"Garratty","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood.V11.10.929.929","article-title":"Reticulocytopenia in autoimmune hemolytic anemia","volume":"11","author":"Crosby","year":"1956","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0025","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bmj.2.6100.1444","article-title":"Reticulocytopenia and \"absence\" of red cell autoantibodies in immune haemolytic anaemia","volume":"2","author":"Hegde","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7326\/0003-4819-93-2-231","article-title":"Delayed hemolytic transfusion reaction presenting as sickle-cell crisis","volume":"93","author":"Diamond","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1537-2995.1997.37497265334.x","article-title":"Severe reactions associated with transfusion of patients with sickle cell disease","volume":"37","author":"Garratty","year":"1997","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tmrv.2019.09.007","article-title":"The role of complement in post-transfusion hemolysis and hyperhemolysis reaction","volume":"33","author":"Roumenina","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.transci.2014.08.018","article-title":"Efficacy and safety of plasma exchange: an 11-year single-center experience of 2730 procedures in 317 patients","volume":"51","author":"Cid","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0050","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2215\/CJN.05830519","article-title":"Complement activation and thrombotic microangiopathies","volume":"14","author":"Palomo","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/1024533042000205478","article-title":"Hyperhaemolysis syndrome in a patient with myelofibrosis","volume":"9","author":"Treleaven","year":"2013","journal-title":"Hematology"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10245330500155168","article-title":"Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood","volume":"10","author":"Win","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0065","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1537-2995.2005.00608.x","article-title":"Hyperhemolysis syndrome in anemia of chronic disease","volume":"45","author":"Darabi","year":"2005","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-3148.2011.01095.x","article-title":"Hyperhaemolysis syndrome treated with corticosteroids and darbopoietin in a patient with mantle cell lymphoma","volume":"22","author":"Babb","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-3148.2011.01096.x","article-title":"A life-threatening episode of treatment-resistant haemolysis in a pregnant patient with dyserythropoietic anaemia (CDA) type I","volume":"22","author":"Bank","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/tme.12104","article-title":"Hyperhaemolysis in a patient with chronic lymphocytic leukaemia","volume":"24","author":"Rogers","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/trf.12876","article-title":"Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab","volume":"55","author":"Gupta","year":"2015","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0090","first-page":"180526","article-title":"Hyperhemolysis syndrome without underlying hematologic disease","volume":"2015","author":"Eberly","year":"2015","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0095","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.tmrv.2020.06.002_bb0100","first-page":"S47","article-title":"Pathogenesis and mechanisms of antibody-mediated hemolysis","volume":"55","author":"Flegel","year":"2015","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1537-2995.2008.01693.x","article-title":"Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review","volume":"48","author":"Win","year":"2008","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-3148.2011.01131.x","article-title":"Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report","volume":"22","author":"Win","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1537-2995.1997.37497265338.x","article-title":"The sickle cell hemolytic transfusion reaction syndrome","volume":"37","author":"Petz","year":"1997","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tmrv.2005.11.002","article-title":"Bystander immune cytolysis","volume":"20","author":"Petz","year":"2006","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.1300880","article-title":"Antibody polyreactivity in health and disease: statu variabilis","volume":"191","author":"Dimitrov","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0130","doi-asserted-by":"crossref","first-page":"26696","DOI":"10.1074\/jbc.M702751200","article-title":"Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions","volume":"282","author":"Dimitrov","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0135","series-title":"Immune hemolytic anemias","first-page":"541","article-title":"Hemolytic transfusion reactions","author":"Petz","year":"2004"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0140","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0145","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0150","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1111\/trf.15445","article-title":"A case-control analysis of hyperhemolysis syndrome in adults and laboratory correlates of complement involvement","volume":"59","author":"Merrill","year":"2019","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2020.06.002_bb0155","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/trf.14431","article-title":"Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition","volume":"58","author":"Mwesigwa","year":"2018","journal-title":"Transfusion (Paris)"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796320300304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796320300304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:19:13Z","timestamp":1760138353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796320300304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0887796320300304"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2020.06.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhemolytic Transfusion Reaction in Non-Hemoglobinopathy Patients and Terminal Complement Pathway Activation: Case Series and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}